X4 Pharmaceuticals shares rose in premarket trading Tuesday after the company received a fast track designation from regulators for its treatment of chronic neutropenia. Shares traded 7.7% higher ...

Patients in the US with the ultra-rare disease WHIM syndrome now have their first approved treatment, after X4 Pharma’s Xolremdi was given a green light by the FDA. Oral CXCR4 antagonist ...

Found the BMW X4 of your dreams? Now you want to know all about it! With the help of Parkers, you can find out all of the key specs about the BMW X4 from fuel efficiency in MPG and top speed in MPH, ...

Principles in motorcycle engine design make sense for aviation.